Related references
Note: Only part of the references are listed.Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer
R. D. Nipp et al.
ANNALS OF ONCOLOGY (2019)
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R. McCurdy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Pain Syndromes and Management in Adult Hematopoietic Stem Cell Transplantation
Joseph D. Ma et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
What Do None, Mild, Moderate, Severe, and Very Severe Mean to Patients With Cancer? Content Validity of PRO-CTCAE (TM) Response Scales
Thomas M. Atkinson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Experiences of Inpatient Bone Marrow Transplantation Nurses and Providers Using Electronic Symptom Reporting
Ashley Leak Bryant et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials
Yongchun Liang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Midori Nakagaki et al.
SUPPORTIVE CARE IN CANCER (2017)
A review of infectious complications after haploidentical hematopoietic stem cell transplantations
Erden Atilla et al.
INFECTION (2017)
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
Ethan Basch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal Study
Peter Esser et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Advances in the understanding and management of mucositis during stem cell transplantation
Joanne M. Bowen et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2017)
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data
Angela K. Green et al.
ONCOLOGIST (2015)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C. Dueck et al.
JAMA ONCOLOGY (2015)
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza et al.
BLOOD (2014)
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Jennifer L. Hay et al.
QUALITY OF LIFE RESEARCH (2014)
Feasibility of Frequent Patient-Reported Outcome Surveillance in Patients Undergoing Hematopoietic Cell Transplantation
William A. Wood et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study Protocol
Margaret F. Bevans et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2011)
Sleep Disturbance in Hospitalized Recipients of Stem Cell Transplantation
Laura Boonstra et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2011)
Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory Cytokines
Daihong Liu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)
Margaret F. Bevans et al.
SUPPORTIVE CARE IN CANCER (2008)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Share Paper
